Lifestyle coaching may slow kidney disease progression
NCT ID NCT01194518
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a tailored lifestyle counseling program for 120 adults with early-stage chronic kidney disease (CKD). Participants received personalized advice based on their readiness to change, focusing on diet, exercise, and kidney health knowledge. The goal was to see if this program could improve kidney function, waist and hip measurements, health behaviors, and quality of life over 30 months compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Lifestyle counseling program
- What this could lead to
- If successful, this program could help people with early-stage chronic kidney disease adopt healthier habits and slow kidney function decline.
- What could go wrong
- This is a completed study with 120 participants, so results are available but may not apply to all CKD patients. Lifestyle changes can be hard to maintain long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cheng Kung University
Tainan, 70101, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app hypnotize away back pain?
- Can a new graft keep dialysis access working longer?
- Could a simple health chat slash heart disease and cancer risk?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates